back

FDA Rejects Avastin for Late-Stage Breast Cancer

11/18/2011

After reviewing extensive research, the FDA has revoked its approval of Avastin for the treatment of breast cancer. The ruling followed the unanimous advice of a June 2011 advisory panel, which found that the cancer drug carries major risks but few benefits for women with late-stage breast cancer. Genentech, which makes Avastin, will continue their current study of Avastin in breast cancer patients to be completed in 2016. The drug is still available for treatment of other types of cancers. VIEW FULL ARTICLE

Media, News & Events

Georgia Cancer Trial Finders Provider Engagement Webinar

Join us for a 35-minute Georgia Cancer Trial Finders Provider Engagement Webinar on March 26 from 12:15–12:50 PM (ET) featuring Dr. Trevor Feinstein, Chief Medical Officer of Georgia CORE, and Dr. Crain Garrott, Past President of the Georgia Society of Clinical Oncology (GASCO).

Because many referrals to Georgia Cancer Trial Finders originate from clinical teams, increasing provider awareness of this res

3/13/2026

Clinical Trials, Doctors & Cancer Centers

Hearts Aligned Integrative Educational Conference

This gathering is more than a conference. It is a coming together of medical professionals, integrative practitioners, community leaders, sponsors, and advocates who believe cancer care should include the whole person — body, mind, and spirit. Together, we are creating space for education, empowerment, and expanded access to integrative services for cancer patients, survivors, and caregivers.

3/09/2026